Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

ClinicalTrials.gov ID: NCT07817251

Public ClinicalTrials.gov record NCT07817251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 14, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety And Tolerability of 3 Switch Regimens From Semaglutide 1.0 mg and 2.0 mg to Co-Administered Cagrilintide and Semaglutide (Cagrisema) in Participants With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have type 2 diabetes. All participants will get CagriSema, the treatment being tested. Participants will be in this clinical study for about 6 months.

Study identification

NCT ID
NCT07817251
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2026 (Actual)
Primary completion
Jun 9, 2027 (Estimated)
Completion
Jul 21, 2027 (Estimated)
Last update posted
Sep 30, 2026

2026 – 2027

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
40
Facility City State ZIP Site status
Gilbert Center For Family Medicine Gilbert Arizona 85296 Recruiting
Ark Clinical Research Fountain Valley California 92708 Recruiting
Thrive Clinical Research Group Glendora California 91740 Recruiting
Scripps Whittier Diabetes Inst La Jolla California 92037 Recruiting
Downtown LA Res Ctr. Inc. Los Angeles California 90017 Recruiting
Valley Clinical Trials, Inc. Northridge California 91325 Recruiting
Dream Team Clinical Research Pomona California 91767 Recruiting
Clinical Trials Research_Sacramento Sacramento California 95821 Recruiting
Linda Vista Health Care Ctr San Diego California 92111 Recruiting
Chase Medical Research LLC Waterbury Connecticut 06708 Recruiting
Northeast Research Institute Fleming Island Florida 32003 Recruiting
AGA Clinical Trial Hialeah Florida 33012 Recruiting
Adult Medicine of Lake County, Inc Mt. Dora Florida 32757 Recruiting
Optimal Research Sites Orange City Florida 32763 Recruiting
Metabolic Research Institute Inc West Palm Beach Florida 33401 Recruiting
East West Med Res Inst Honolulu Hawaii 96814 Recruiting
Endeavor Health Skokie Illinois 60077 Recruiting
Iowa Diabetes & Endo Res Ctr West Des Moines Iowa 50266 Recruiting
Alliance for Multispecialty Research Newton Kansas 67114 Recruiting
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 Recruiting
Northern Pines Hlth Ctr, PC Buckley Michigan 49620 Recruiting
Palm Research Center Inc-Vegas Las Vegas Nevada 89128 Recruiting
Albuquerque Clinical Trials Inc. Albuquerque New Mexico 87102 Recruiting
PharmQuest Life Sciences LLC Greensboro North Carolina 27408 Recruiting
Accellacare Wilmington Wilmington North Carolina 28401 Recruiting
Advanced Medical Research Maumee Ohio 43537 Not yet recruiting
Clinical Research Associates Nashville Tennessee 37203 Recruiting
Amarillo Med Spec LLP Amarillo Texas 79124 Recruiting
Texas Diabetes & Endocrinology Austin Texas 78749 Recruiting
North Texas Endocrine Center Dallas Texas 75231 Recruiting
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 Recruiting
JCCT- Juno NW Houston Houston Texas 77040 Recruiting
Sante Clinical Research Kerrville Texas 78028 Recruiting
DCOL Ctr for Clin Res Longview Texas 75605 Recruiting
North Hills Medical Research Inc North Richland Hills Texas 76180 Recruiting
NE Clin Res of San Antonio San Antonio Texas 78233 Not yet recruiting
J.Lewis Research Inc Salt Lake City Utah 84109 Recruiting
Diabetes & Endo Treatment Spec Sandy City Utah 84093 Not yet recruiting
Chrysalis Clinical Research St. George Utah 84790 Recruiting
Tidewater Physicians Multispecialty Group Newport News Virginia 23606 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07817251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2026 · Synced Oct 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07817251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →